Mick Jagger's Heart Procedure May Be a Boon to Valve Makers
Mick Jagger during the Rock in Rio Lisbon music festival in Lisbon on May 29, 2014.
Photographer: Pedro Fiúza/Getty Images via Getty Images
This article is for subscribers only.
A successful heart procedure for Rolling Stones frontman Mick Jagger may provide a spark for device makers that manufacture the type of heart valve used in his surgery, according to Wells Fargo.
MedTech companies that have helped pioneer and produce the aortic valve replacement procedure, like Edwards Lifesciences Corp. and Medtronic PLC, may see a boost in demand and awareness after the 75-year-old took to Twitter to thank the doctors, Wells Fargo analyst Larry Biegelsen wrote in a note to clients.